<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - New Report Highlights Risks of U.S. Drug Reimportation
Image Overlay - New Report Highlights Risks of U.S. Drug Reimportation

New Report Highlights Risks of U.S. Drug Reimportation

September 6, 2019

New Report Highlights Risks of U.S. Drug Reimportation

While the reimportation of drugs into the U.S. from abroad is a popular topic among politicians and advocates looking for ways to reduce domestic healthcare costs, the research arm of the Healthcare Distribution Alliance has released a new report highlighting some little-discussed costs and risks associated with reimportation. Yourway is no stranger to logistical challenges and is monitoring this issue.

 Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply New England

April 14-15, 2026
Boston, MA

GCSG 2026 US Conference

April 26-29, 2026
San Diego, CA

Media

Articles

White-Glove by Design: The Yourway Standard in Clinical Logistics

Open chat
Come chat with us!
Hello! How can I help you?